Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE004676 |
ID: | TCMBANKHE004676 |
植物拉丁名: |
|
功能与主治: | To dispel wind-damp, warm channels and relieve pain, disperse concretion and conglomeration./Wind stroke with hemiplegia, wind-cold-damp impediment, lumbago, mounting qi , concretion conglomeration accumulation and gathering, qi dysentery. |
药用植物名: | 木天蓼 |
药用部位: | branchlet-leaf |
TCM_ID_id: | 4502 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN001181 | dihydronortoxiferine i | C38H40N4 | 552.7 g/mol | CC=C1CN2CCC34C2CC1C5=CN6C7C(=CN(C53)C8=CC=CC=C48)C9CC1C7(CCN1CC9=CC)C1=CC=CC=C16 | |
| TCMBANKIN003128 | (+)-Neomatatabiol | C10H18O2 | 170.25 g/mol | CC1CCC2C1C(OCC2C)O | |
| TCMBANKIN005839 | Actinidine | C09910; actinidine; (7S)-4,7-dimethyl-6,7-dihydro-5H-cyclopenta[d]pyridine; 5H-2-Pyrindine, 6,7-dihydro-4,7-dimethyl-, (S)-; CHEBI:2443; (7S)-4,7-dimethyl-2-pyrindan; (7S)-4,7-dimethyl-6,7-dihydro-5H-cyclopenta[c]pyridine; 524-03-8 | C10H13N | 147.22 | CC1CCC2=C1C=NC=C2C |
| TCMBANKIN006443 | neonepetalactone | C10H14O2 | 166.22 g/mol | CC1COC(=O)C2=C(CCC12)C | |
| TCMBANKIN008707 | Iristectorin A | 5-hydroxy-3-(3-hydroxy-4-methoxy-phenyl)-6-methoxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one; 5-hydroxy-3-(3-hydroxy-4-methoxyphenyl)-6-methoxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one; 5-hydroxy-3-(3-hydroxy-4-methoxyphenyl)-6-methoxy-7-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-4-chromenone; iristectorin a; 5-hydroxy-3-(3-hydroxy-4-methoxy-phenyl)-6-methoxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-chromen-4-one; 5-hydroxy-3-(3-hydroxy-4-methoxy-phenyl)-6-methoxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-chromone | C23H24O12 | 492.43 | COC1=C(C=C(C=C1)C2=COC3=CC(=C(C(=C3C2=O)O)OC)OC4C(C(C(C(O4)CO)O)O)O)O |
| TCMBANKIN011296 | 7-hydroxydihydromatatabiether | C10H18O2 | CC1COC2(CCC1C2CO)C | ||
| TCMBANKIN013074 | iridotectoral a | C30H46O5 | 486.7 g/mol | CC(=CCCC(=CC=CC(=CC1CC2(C(C(=C(C)C=O)CCC2(C)O)CCCO)C(O1)O)C)C)C | |
| TCMBANKIN013339 | 20-hydroxydihydrorankinidine | C20H26N2O4 | 358.4 g/mol | CCC1(CNC2CC3(C4CC1C2CO4)C5=CC=CC=C5N(C3=O)OC)O | |
| TCMBANKIN014236 | matatabiol | C10H16O2 | CC1COC2(C1CC=C2C)CO | ||
| TCMBANKIN017928 | 2,2-dimethyl-2h-1-benzopyran-6-carboxylic acid methyl ester | 2,2-dimethyl-2h-1-benzopyran-6-carboxylicacid methyl ester | C13H14O3 | 218.25 g/mol | CC1(C=CC2=C(O1)C=CC(=C2)C(=O)OC)C |
| TCMBANKIN019182 | isodiospyrin | C22H14O6 | 374.3 g/mol | CC1=CC2=C(C(=O)C=CC2=O)C(=C1C3=C4C(=O)C=CC(=O)C4=C(C=C3C)O)O | |
| TCMBANKIN019902 | 3, 4-dihydroxybenzoicacid4-O-(4′-O-methyl)-β-D-glucopyranoside | ||||
| TCMBANKIN021648 | iridomyrmecin | C10H16O2 | 168.23 g/mol | CC1CCC2C1COC(=O)C2C | |
| TCMBANKIN023506 | 3,4-DIMETHYLBIPHENYL | 4433-11-8; 1,2-dimethyl-4-phenyl-benzene; 1,1'-Biphenyl, 3,4-dimethyl-; 1,2-dimethyl-4-phenylbenzene | C14H14 | 182.26 g/mol | CC1=C(C=C(C=C1)C2=CC=CC=C2)C |
| TCMBANKIN023842 | matricaria ester | C11H10O2 | 174.2 g/mol | CC=CC#CC#CC=CC(=O)OC | |
| TCMBANKIN028120 | Matatabiether | 2,5-dimethyl-9-methylidene-4-oxabicyclo[3.3.1]nonane; matatabiether; AC1NSXW1 | 166.29 | CC1COC2(CCCC1C2=C)C | |
| TCMBANKIN028730 | iridodiol | C10H20O2 | 172.26 g/mol | CC1CCC(C1CO)C(C)CO | |
| TCMBANKIN028868 | neonootkatol | 314.46 | COC1=C(C=CC(=C1)CC(CCCCCC2=CC=CC=C2)O)O | ||
| TCMBANKIN029353 | isoiridomyrmecin | C10H16O2 | 168.23 g/mol | CC1CCC2C1COC(=O)C2C | |
| TCMBANKIN030492 | isoneotriptophenolide | AC1NSX36; ACMC-20dhnb; Phenanthro[1,2-c]furan-1(3H)-one,3b,4,5,9b,10,11-hexahydro-8-hydroxy-6-methoxy-9b-methyl-7-(1-methylethyl)-,(3bR,9bS)- (9CI); 8-hydroxy-6-methoxy-9b-methyl-7-propan-2-yl-3,3b,4,5,10,11-hexahydronaphtho[2,1-e][2]benzofuran-1-one | C21H26O4 | 342.4 g/mol | CC(C)C1=C(C=C2C(=C1OC)CCC3C2(CCC4=C3COC4=O)C)O |
| TCMBANKIN032436 | xylylic acid nitrile | xylylicacidnitrile | C9H9N | ||
| TCMBANKIN036315 | allomatatabiol | C10H16O2 | 168.23 g/mol | CC1COCC2=C(C(CC12)O)C | |
| TCMBANKIN036927 | Quercetin-3-O-[α-rhamnopyranosyl-(1→4)-rhamnopyranosyl-(1→6)]-β-galactopyranoside | ||||
| TCMBANKIN040167 | kaempferol-3-o-[α-rhamnopyranosyl-(1→4)-rhamnopyranosyl-(1→6)-β-galactopyranoside] | C33H40O19 | |||
| TCMBANKIN041489 | Nepetalactone | 166.22 g/mol | |||
| TCMBANKIN042670 | Iristectorin B | 5-hydroxy-3-(4-hydroxy-3-methoxy-phenyl)-6-methoxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-chromone; 5-hydroxy-3-(4-hydroxy-3-methoxyphenyl)-6-methoxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one; iristectorin b; 5-hydroxy-3-(4-hydroxy-3-methoxy-phenyl)-6-methoxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one; 5-hydroxy-3-(4-hydroxy-3-methoxyphenyl)-6-methoxy-7-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-4-chromenone; 5-hydroxy-3-(4-hydroxy-3-methoxy-phenyl)-6-methoxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-chromen-4-one | C23H24O12 | 492.4 g/mol | COC1=C(C=CC(=C1)C2=COC3=CC(=C(C(=C3C2=O)O)OC)OC4C(C(C(C(O4)CO)O)O)O)O |
| TCMBANKIN042726 | Isokobusone | (1S,5R,9R)-5-hydroxy-11,11-dimethyl-4-methylidenebicyclo[7.2.0]undecan-8-one; AC1OF35U | 222.32 g/mol | ||
| TCMBANKIN042944 | iridodialo-β-d-gentiobioside | C22H36O12 | |||
| TCMBANKIN045017 | Isoactinidialactone | ||||
| TCMBANKIN046424 | actinidialactone | C10H14O2 | 166.22 g/mol | CC1C2CC=C(C2(OC1=O)C)C | |
| TCMBANKIN047194 | Actinidiolide | 178.23 g/mol | |||
| TCMBANKIN049851 | actinidol | C12H18O2 | 194.27 g/mol | CC(C1C=C2C(O1)C=CCC2(C)C)O | |
| TCMBANKIN050190 | 3-phenglundecane | 232.404 | |||
| TCMBANKIN058093 | Sumiki's acid | 5-methylol-2-furoic acid; 5-(hydroxymethyl)furan-2-carboxylic acid; 2-Furoic acid, 5-(hydroxymethyl)-; 5-Hydroxymethyl-furan-2-carboxylic acid; 6338-41-6; NSC 40739; 2-Furancarboxylic acid, 5-(hydroxymethyl)- (9CI); 5-Hydroxymethyl-2-furoic acid; 2-Furoic acid, 5-(hydroxymethyl)- (8CI); 5-(hydroxymethyl)-2-furancarboxylic acid; ST5227816; BAS 00404252; 5-Hydroxymethyl-2-furancarboxylic acid; EC-000.1550; NSC40739; 2-Furancarboxylic acid, 5-(hydroxymethyl)-; InChI=1/C6H6O4/c7-3-4-1-2-5(10-4)6(8)9/h1-2,7H,3H2,(H,8,9; 5-(Hydroxymethyl)-2-furoic acid; Oprea1_060549; NCGC00091546-01; Oprea1_518608; 5-hydroxymethyl-2-Furancarboxylic acid; | C6H6O4 | 142.11 | C1=C(OC(=C1)C(=O)O)CO |
| TCMBANKIN058114 | trans-caffeic acid | 3-(3,4-dihydroxy-phenyl)-acrylic acid; caffeic acid; Caffeate; Lopac-C-0625; 71693-97-5; DivK1c_006624; KBio2_007302; (Z)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; NCGC00015206-02; CAS-3331-39-5; 60020_FLUKA; AI3-63211; 3-(3,4-Dihydroxyphenyl)-2-propenoic acid polymer; (E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; NSC623438; 4-(2'-Carboxyvinyl)-1,2-dihydroxybenzene; KBio2_004734; (2Z)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; CHEMBL1320034; AIDS-002287; AIDS002287; 501-16-6; CHEBI:36281; Prestwick1_000902; KBio1_001568; 3-(3,4-Dihydroxyphenyl)-2-propenoic acid; AKOS000273846; OR1165; SMR000058214; Spectrum2_001612; 3,4-dihydroxycinnamate; (Z)-3-(3,4-dihydroxyphenyl)acrylic acid; Caffeicacid; KOP; AC1NO658; CCRIS 847; Caffeic acid dehydrogenation homopolymer; SPECTRUM1503987; Spectrum4_001694; SCHEMBL3682144; NCGC00017364-01; NCGC00022654-08; 4-(2-Carboxyethenyl)-1,2-dihydroxybenzene; 78734C5A-1281-44D4-B8A0-A3188AD437E3; cis-Caffeic acid; 3-(3,4-dihydroxyphenyl)acrylic acid; Cinnamic acid, 3,4-dihydroxy-; KBioGR_001988; 3,4-Dihydroxybenzeneacrylic acid; 3,4-dihydroxycinnamic acid; trans-caffeic acid; AIDS-026339; NCGC00015206-01; HSDB 7088; ZINC4482687; (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; 3-(3,4-dihydroxyphenyl)prop-2-enoate; Isocaffeic acid; SBB006475; InChI=1/C9H8O4/c10-7-3-1-6(5-8(7)11)2-4-9(12)13/h1-5,10-11H,(H,12,13)/b4-2; NCGC00017364-02; EU-0100208; C01197; MolPort-001-759-162; KBioSS_002166; Caffeic acid pure; caffeic acid ; trans-Caffeate; (2E)-3-(3,4-dihydroxyphenyl)acrylic acid; NSC 57197; (2E)-3-(3,4-Dihydroxyphenyl)-2-propenoic acid; Spectrum_001686; 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-, (E)-; KBio2_002166; Caffeic acid, cis-; 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-; 3,4-Dihydroxybenzeneacrylate; 3-(3,4-Dihydroxy phenyl)-2-propenoic acid; 4361-87-9; 3,4-Dihydroxy-trans-cinnamate; caffeicacid; AR-360/40806927; EINECS 206-361-2; 60018_FLUKA; Caffeic acid polymer; (E)-3-(3,4-dihydroxyphenyl)acrylic acid; NCGC00022654-04; ZX-AL002121; C0625_SIGMA; SDCCGMLS-0002982.P003; 3-(3,4-Dihydroxyphenyl)-2-propenoic acid, homopolymer; SPBio_001643; 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)- (9CI); NCGC00017364-03; 3-(3,4-dihydroxyphenyl)prop-2-enoic acid; AC1LU7RL; SPBio_002943; CHEBI:16433; AIDS026339; 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-, homopolymer; CHEBI:17395; TNP00311; SpecPlus_000528; Prestwick0_000902; MLS000069738; 3,4-dihydroxy-cinnamic acid; 3-(3,4-Dihydroxyphenyl)propenoic acid; NCI60_004400; NSC57197; Caffeic; Lopac-C-0625; NCGC00015206-01; Caffeic acid; cis-Caffeic acid; NCGC00017364-01; (Z)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; C01481; 331-39-5; NCGC00015206-02; CAS-3331-39-5; 3,4-Dihydroxycinnamic acid; CHEBI:17395; (2Z)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; TNP00311; (Z)-3-(3,4-dihydroxyphenyl)acrylic acid; Caffeate; 1- coffee acid | C9H8O4 | 180.16 g/mol | C1=CC(=C(C=C1C=CC(=O)O)O)O |
| TCMBANKIN058348 | Benzenepropanol | phenylpropyl alcohol;benzylethyl-alcohol;NCGC00165987-01; 3-Benzenepropanol; Hydrocinnamyl alcohol; 3-Phenylpropan-1-ol; 1-Propanol, 3-phenyl-; BRN 1857542; 4-06-00-03198 (Beilstein Handbook Reference); FEMA No. 2885; gamma-Phenylpropanol; (3-Hydroxypropyl)benzene; 3-Phenylpropanol; Hydrocinnamic alcohol; .gamma.-Phenylpropanol; NSC 16942; NSC16942; 3-Phenyl-n-propanol; 1335-12-2; EINECS 215-621-4; 79000_FLUKA; EINECS 204-587-6; AI3-02067; benzene propanol; .gamma.-Phenylpropyl alcohol; 3-Phenylpropyl alcohol; CCRIS 3200; 3-Phenyl-1-propanol (natural); W288500_ALDRICH; Phenylpropyl alcohol; InChI=1/C9H12O/c10-8-4-7-9-5-2-1-3-6-9/h1-3,5-6,10H,4,7-8H; 3-Phenyl-1-propanol; 140856_ALDRICH; Dihydrocinnamal alcohol; ZINC01571261; 1-Propanol, phenyl-; 122-97-4; 1-Hydroxy-3-phenylpropane; 3-PHENYL-PROPAN-(1)-OL; Benzylethyl alcohol; 3-Phenylpropanol-1 | C9H12O | 136.19 | C1=CC=C(C=C1)CCCO |
| TCMBANKIN058596 | 5-hydroxymatrine | (+)-Sophoranol; 3411-37-8; CHEMBL3590537; 411S378; MolPort-039-338-505; C17069; Sophoranol; SCHEMBL564487; 5-Hydroxymatrine; CHEBI:80905; sophoranol; (+)-sophoranol | C15H24N2O2 | 264.36 g/mol | C1CC2C3CCCN4C3C(CCC4)(CN2C(=O)C1)O |
| TCMBANKIN060588 | nepetalactone | C10H14O2 | 166.22 g/mol | CC1CCC2C1C(=O)OC=C2C | |
| TCMBANKIN060589 | Dihydronepetalactone | C10H16O2 | 168.23 g/mol | CC1CCC2C1C(=O)OCC2C | |
| TCMBANKIN060592 | (+)-Neomatatabiol | C10H18O2 | 170.25 g/mol | CC1CCC2C1C(OCC2C)O | |
| TCMBANKIN060612 | neonepetalactone | C10H14O2 | 166.22 g/mol | CC1COC(=O)C2=C(CCC12)C | |
| TCMBANKIN061498 | Iristectorin A | 5-hydroxy-3-(3-hydroxy-4-methoxy-phenyl)-6-methoxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one; 5-hydroxy-3-(3-hydroxy-4-methoxyphenyl)-6-methoxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one; 5-hydroxy-3-(3-hydroxy-4-methoxyphenyl)-6-methoxy-7-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-4-chromenone; iristectorin a; 5-hydroxy-3-(3-hydroxy-4-methoxy-phenyl)-6-methoxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-chromen-4-one; 5-hydroxy-3-(3-hydroxy-4-methoxy-phenyl)-6-methoxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-chromone;iristectorin | C23H24O12 | 492.43 | COC1=C(C=C(C=C1)C2=COC3=CC(=C(C(=C3C2=O)O)OC)OC4C(C(C(C(O4)CO)O)O)O)O |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab